Mission & Margin

$11M for one patient's drug: why gene therapy threatens plans more than GLP-1s | Peter Marino

26:58

One member at Neighborhood Health Plan of Rhode Island carries an $11 million annual maintenance drug. For that same cost, Peter Marino says he could vaccinate the entire state for the flu. Peter tells Trey why community plan leaders should be far more worried about gene therapy than GLP-1s.

Peter has run Neighborhood as CEO for 11 years and grew the plan from 92,000 to 220,000 members and $450…